Cybernius Medical Ltd. (CML) is a medical software company, which is committed to the effective utilization of proven, leading edge computing technology in the health care industry.
CML, has been serving the international Nephrology community for almost 20 years. CML’s flagship product, cyberREN®, is a powerful renal patient care information management system, with comprehensive medical documentation and analysis tools that address the broad range of functionality required by clinics and hospitals engaged in the treatment of kidney disease.
cyberREN, which serves thousands of users worldwide, goes far beyond the basic electronic medical record and is the most current and sophisticated Nephrology EMR solution available. Users are provided with complete and easy access to patient information, empowering them to significantly improve the quality and efficiency of patient care. Due to CML’s commitment to quality and client satisfaction, CML has been selected as the clinical record management system for many major facilities world-wide, including several very prestigious organizations.
Company Details
- Employees
- 12
- Founded
- -
- Address
- The Broad Range Of Functionality Required By Clinics And Hospitals Engaged In The Treatment Of Kidney Disease.
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- cyberren.com
- Keywords
- IT Consulting.
Cybernius Medical Ltd. Questions
Cybernius Medical Ltd.'s website is cyberren.com
Cybernius Medical Ltd.'s LinkedIn profile is https://ca.linkedin.com/company/cybernius-medical-ltd.
Cybernius Medical Ltd. has
12 employees.
View email and phone details for 12
employees at Cybernius Medical Ltd..
Cybernius Medical Ltd.'s industry is
Software Development
Cybernius Medical Ltd.'s top competitors are
Atlas Power Technologies Inc.,
Nanostics Inc.,
Us Ravens Logistics,
Finning,
Wrk,
Givelify,
Bioware,
Subnet Solutions Inc.,
Drivewyze By Fleetworthy,
Coparenter.
Cybernius Medical Ltd.'s categories are Software Development
Cybernius Medical Ltd.'s founding year is 1993
